*DJ Medical Marijuana, Inc. CEO Chosen To Present Oral Comments At FDA's Public Hearing On Products Containing Cannabis And Cannabis-Derived Compounds >MJNA
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
May 21, 2019 09:00 ET (13:00 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Comment(0)
Reason For Report